MedTrace Logo

Use of Erythromycin in Mustard-Induced Bronchiolitis

NCT00367419 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2008-11-05

No results posted yet for this study

Summary

We looked for the effectiveness of low-dose long-term prescription of erythromycin in mustard-induced bronchiolitis obliterans

Conditions

  • Bronchiolitis Obliterans
  • Acute Obliterating Bronchiolitis

Interventions

DRUG

Erythromycin

Sponsors & Collaborators

  • Baqiyatallah Medical Sciences University

    lead OTHER

Principal Investigators

  • Mostafa Ghanei, Professor · Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00367419 on ClinicalTrials.gov